Joo-young Kim
Daegu, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Targeting RBM39 with Tasisulam enhances TRAIL-induced apoptosis through DR5 upregulation and Bcl-2 downregulation in renal cell carcinoma.
Journal: Biochemical pharmacology
Published: January 06, 2025
Recent advances in anticancer mechanisms of molecular glue degraders: focus on RBM39-dgrading synthetic sulfonamide such as indisulam, E7820, tasisulam, and chloroquinoxaline sulfonamide.
Journal: Genes & genomics
Published: August 11, 2024
Suppression of TBCK enhances TRAIL-mediated apoptosis by causing the inactivation of the akt signaling pathway in human renal carcinoma Caki-1 cells.
Journal: Genes & genomics
Published: July 20, 2023
MiR-1208 Increases the Sensitivity to Cisplatin by Targeting TBCK in Renal Cancer Cells.
Journal: International journal of molecular sciences
Published: June 13, 2019
Neferine-induced apoptosis is dependent on the suppression of Bcl-2 expression via downregulation of p65 in renal cancer cells.
Journal: Acta biochimica et biophysica Sinica
Published: December 31, 2018
Superficial course of the medial plantar nerve: case report.
Journal: Anatomy & cell biology
Published: June 12, 2018
Metformin-induced apoptosis facilitates degradation of the cellular caspase 8 (FLICE)-like inhibitory protein through a caspase-dependent pathway in human renal cell carcinoma A498 cells.
Journal: Oncology letters
Published: February 12, 2018
miR-148a increases the sensitivity to cisplatin by targeting Rab14 in renal cancer cells.
Journal: International journal of oncology
Published: November 25, 2016
Last Updated: 09/26/2026